Koligo Therapeutics (ASX:KOL) Other Financing: A$0.00 Mil (TTM As of . 20)


What is Koligo Therapeutics Other Financing?

Koligo Therapeutics ASX:KOL Other Financing is A$0.00 Mil as of . 20.

Koligo Therapeutics's Other Financing for the six months ended in . 20 was A$0.00 Mil.

Koligo Therapeutics's Other Financing for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

Koligo Therapeutics Other Financing Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Other Financing Chart

Koligo Therapeutics Annual Data
Trend
Other Financing

Koligo Therapeutics Semi-Annual Data
Other Financing

Koligo Therapeutics Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of A$0.00 Mil mean?
Koligo Therapeutics (ASX:KOL) has a Other Financing of A$0.00 Mil as of . 20. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' Other Financing too high?
Koligo Therapeutics' current Other Financing is A$0.00 Mil.
How does Koligo Therapeutics' Other Financing compare to ?
Koligo Therapeutics' Other Financing of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Koligo Therapeutics and its competitors. Koligo Therapeutics's current Other Financing is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Other Financing of A$0.00 Mil. The current Other Financing is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Other Financing is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies